GENNECS – El Daba Holding

GENNECS is part of a Holding Company, working across multiple industries, where GENNECS is leading the pharmaceutical arm of the group, with local, regional & global outreach.

GENNECS portfolio is comprised of a wide range of moleculare, including the production of Under Licensed Original Products, Generics, Modified Generics / Super-Generics, Vaccines, Food Supplements, as well as various Medical Devices & Laboratory Equipment. In addition, our Company is the Regional Distribution and Agency holder for multiple biotech products.

MISSION

To develop and produce innovative medical products aimed at improving treatment efficacy and safety

VISION

Protecting and supporting people facing health challenges

GENNECS GROUP

Gennecs Pharmaceuticals Ltd is a research industrial -based pharmaceutical company, an industry leader in the development and production of innovative & genetics medicines that address common medical needs.

Gennecs Pharmaceuticals Ltd is dedicated for commercialization of products for the international markets, emerging markets , Africa & MENA.

Active around the globe with partnerships in Canada, Africa, Gulf & Egypt

Gennecs Pharmaceuticals also offers a range of clinical, non-clinical, environmental and other development services for a wide range of applications through partnering with the state of art laboratory & facilities employing the latest technologies available in both equipment and methods.

GENNECS PHARMACEUTICALS

Gennecs is a multidisciplinary organization with expertise on the whole pharmaceutical product cycle; from development to commercialization

Commercial Operations with dedicated OTC and Rx sales force, with a broad reach within the emerging markets

Manufacturing sites: partnering with more than five state of the art manufacturing facilities which are Local GMP, euGMP, ISO 9001:2015, as well as ISO 13485 compliant

Contract research with focus on custom formulation development as well as analytical development and regulatory support

Distribution and agency holders for multiple biotech products